Kilitch Drugs (India) Ltd.
| BSE: 524500 | Sector: Health care |
| NSE: KILITCH | ISIN Code: INE729D01010 |
| BSE 00:00 | 08 Aug | 161.55 |
3.55 (2.25%) |
OPEN
159.70 |
HIGH
162.60 |
LOW
159.70 |
| NSE 00:00 | 08 Aug | 160.30 |
(%) |
OPEN
161.95 |
HIGH
162.80 |
LOW
159.45 |
| OPEN | 159.70 |
| PREVIOUS CLOSE | 158.00 |
| VOLUME | 848 |
| 52-Week high | 276.40 |
| 52-Week low | 144.30 |
| P/E | 24.66 |
| Mkt Cap.(Rs cr) | 260 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Kilitch Drugs (India) Ltd. (KILITCH) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Sun Pharma.Inds. | 910.50 | -4.70 | -0.51 | 15585.98 |
| Dr Reddy's Labs | 4220.35 | 64.35 | 1.55 | 14405.20 |
| Cipla | 1029.25 | -5.00 | -0.48 | 13091.79 |
| Lupin | 666.05 | -1.90 | -0.28 | 11771.67 |
| Aurobindo Pharma | 568.20 | -0.35 | -0.06 | 11287.14 |
| Divi's Lab. | 3938.65 | 27.60 | 0.71 | 8879.82 |
| Alkem Lab | 2985.40 | -126.25 | -4.06 | 8829.81 |
| Zydus Lifesci. | 360.60 | 3.40 | 0.95 | 7981.90 |
| Glenmark Pharma. | 371.90 | -6.35 | -1.68 | 7567.93 |
| Torrent Pharma. | 1557.25 | 1.55 | 0.10 | 6742.32 |
| Apollo Hospitals | 4428.60 | 55.40 | 1.27 | 6098.30 |
| Ipca Labs. | 1012.10 | -3.05 | -0.30 | 5399.36 |
| Alembic Pharma | 663.80 | -8.85 | -1.32 | 5051.44 |
| Abbott India | 20292.20 | -103.35 | -0.51 | 4919.27 |
| Laurus Labs | 550.80 | 5.55 | 1.02 | 4707.04 |
| Gland Pharma | 2325.55 | 64.65 | 2.86 | 4400.71 |
| Granules India | 313.95 | 3.00 | 0.96 | 3238.44 |
| Glaxosmi. Pharma | 1442.75 | 34.90 | 2.48 | 3217.51 |
| Ajanta Pharma | 1274.85 | -3.90 | -0.30 | 3140.64 |
| Sanofi India | 6512.50 | -26.30 | -0.40 | 2956.60 |
Quick Links for Kilitch Drugs (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
